Class information for:
Level 1: GENERIC SUBSTITUTION//GENERIC DRUGS//GENERIC MEDICINES

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
5560 1606 29.3 46%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
320 3       AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY 39312
1464 2             FOOD AND DRUG LAW JOURNAL//CONFLICT OF INTEREST//ORPHAN DRUGS 7747
5560 1                   GENERIC SUBSTITUTION//GENERIC DRUGS//GENERIC MEDICINES 1606

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GENERIC SUBSTITUTION authKW 1233809 5% 85% 76
2 GENERIC DRUGS authKW 925447 7% 41% 118
3 GENERIC MEDICINES authKW 650953 3% 80% 43
4 REFERENCE PRICING authKW 480782 2% 82% 31
5 GENERIC authKW 407492 7% 20% 106
6 PARALLEL IMPORTS authKW 295783 1% 68% 23
7 BRAND NAME DRUG authKW 285958 1% 79% 19
8 PHARMACEUTICAL POLICY authKW 277996 2% 38% 39
9 DEMAND SIDE MEASURES authKW 214194 1% 87% 13
10 GENERIC ENTRY authKW 210588 1% 92% 12

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Health Policy & Services 49053 29% 1% 463
2 Health Care Sciences & Services 29811 29% 0% 471
3 Economics 9056 26% 0% 418
4 Pharmacology & Pharmacy 2989 27% 0% 428
5 Medicine, General & Internal 793 12% 0% 188
6 Law 428 3% 0% 54
7 Public, Environmental & Occupational Health 371 8% 0% 121
8 Clinical Neurology 239 7% 0% 110
9 Psychiatry 150 5% 0% 74
10 Management 143 2% 0% 40

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SCI TECHNOL INNOVAT NEGLECTED DIS 97772 0% 86% 6
2 WHO ABORATING PHARMACEUT PRICING REIMBU 85549 0% 75% 6
3 AUSTRIAN HLTH 79213 0% 83% 5
4 P CRIBING GRP 76026 1% 29% 14
5 LIVERPOOL HLTH ECON 71565 0% 47% 8
6 PUBL HLTH INTELLIGENCE STRATEG BUSINESS UNIT 67896 0% 71% 5
7 MED REIMBURSEMENT 59407 0% 63% 5
8 HEALTHCARE MANAGEMENT PROGRAMME 57035 0% 100% 3
9 POLISH SOC HLTH ECON 57035 0% 100% 3
10 AUSTRIAN PUBL HLTH 42775 0% 75% 3

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 56851 2% 8% 39
2 PHARMACOECONOMICS 44741 4% 3% 72
3 HEALTH POLICY 41483 5% 3% 83
4 JOURNAL OF HEALTH ECONOMICS 18719 3% 2% 41
5 EUROPEAN JOURNAL OF HEALTH ECONOMICS 16153 1% 4% 24
6 HEALTH AFFAIRS 10826 3% 1% 52
7 INTERNATIONAL JOURNAL OF HEALTH ECONOMICS AND MANAGEMENT 7597 0% 10% 4
8 PHARMACY MANAGEMENT 6910 0% 18% 2
9 HEALTH POLICY AND TECHNOLOGY 5920 0% 4% 7
10 HEALTH ECONOMICS 5812 1% 1% 24

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 GENERIC SUBSTITUTION 1233809 5% 85% 76 Search GENERIC+SUBSTITUTION Search GENERIC+SUBSTITUTION
2 GENERIC DRUGS 925447 7% 41% 118 Search GENERIC+DRUGS Search GENERIC+DRUGS
3 GENERIC MEDICINES 650953 3% 80% 43 Search GENERIC+MEDICINES Search GENERIC+MEDICINES
4 REFERENCE PRICING 480782 2% 82% 31 Search REFERENCE+PRICING Search REFERENCE+PRICING
5 GENERIC 407492 7% 20% 106 Search GENERIC Search GENERIC
6 PARALLEL IMPORTS 295783 1% 68% 23 Search PARALLEL+IMPORTS Search PARALLEL+IMPORTS
7 BRAND NAME DRUG 285958 1% 79% 19 Search BRAND+NAME+DRUG Search BRAND+NAME+DRUG
8 PHARMACEUTICAL POLICY 277996 2% 38% 39 Search PHARMACEUTICAL+POLICY Search PHARMACEUTICAL+POLICY
9 DEMAND SIDE MEASURES 214194 1% 87% 13 Search DEMAND+SIDE+MEASURES Search DEMAND+SIDE+MEASURES
10 GENERIC ENTRY 210588 1% 92% 12 Search GENERIC+ENTRY Search GENERIC+ENTRY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DYLST, P , VULTO, A , SIMOENS, S , (2013) DEMAND-SIDE POLICIES TO ENCOURAGE THE USE OF GENERIC MEDICINES: AN OVERVIEW.EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. VOL. 13. ISSUE 1. P. 59 -72 70 88% 19
2 DUNNE, SS , DUNNE, CP , (2015) WHAT DO PEOPLE REALLY THINK OF GENERIC MEDICINES? A SYSTEMATIC REVIEW AND CRITICAL APPRAISAL OF LITERATURE ON STAKEHOLDER PERCEPTIONS OF GENERIC DRUGS.BMC MEDICINE. VOL. 13. ISSUE . P. - 58 89% 3
3 DUNNE, SS , (2016) WHAT DO USERS OF GENERIC MEDICINES THINK OF THEM? A SYSTEMATIC REVIEW OF CONSUMERS' AND PATIENTS' PERCEPTIONS OF, AND EXPERIENCES WITH, GENERIC MEDICINES.PATIENT-PATIENT CENTERED OUTCOMES RESEARCH. VOL. 9. ISSUE 6. P. 499 -510 46 94% 0
4 FADARE, JO , ADEOTI, AO , DESALU, OO , ENWERE, OO , MAKUSIDI, AM , OGUNLEYE, O , SUNMONU, TA , TRUTER, I , AKUNNE, OO , GODMAN, B , (2016) THE PRESCRIBING OF GENERIC MEDICINES IN NIGERIA: KNOWLEDGE, PERCEPTIONS AND ATTITUDES OF PHYSICIANS.EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. VOL. 16. ISSUE 5. P. 639 -650 46 74% 1
5 DESMARAIS, JE , BEAUCLAIR, L , MARGOLESE, HC , (2011) SWITCHING FROM BRAND-NAME TO GENERIC PSYCHOTROPIC MEDICATIONS: A LITERATURE REVIEW.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 17. ISSUE 6. P. 750-760 46 82% 24
6 COLGAN, S , FAASSE, K , MARTIN, LR , STEPHENS, MH , GREY, A , PETRIE, KJ , (2015) PERCEPTIONS OF GENERIC MEDICATION IN THE GENERAL POPULATION, DOCTORS AND PHARMACISTS: A SYSTEMATIC REVIEW.BMJ OPEN. VOL. 5. ISSUE 12. P. - 38 86% 0
7 CARBON, M , CORRELL, CU , (2013) RATIONAL USE OF GENERIC PSYCHOTROPIC DRUGS.CNS DRUGS. VOL. 27. ISSUE 5. P. 353 -365 40 82% 8
8 DUNNE, S , SHANNON, B , DUNNE, C , CULLEN, W , (2013) A REVIEW OF THE DIFFERENCES AND SIMILARITIES BETWEEN GENERIC DRUGS AND THEIR ORIGINATOR COUNTERPARTS, INCLUDING ECONOMIC BENEFITS ASSOCIATED WITH USAGE OF GENERIC MEDICINES, USING IRELAND AS A CASE STUDY.BMC PHARMACOLOGY & TOXICOLOGY. VOL. 14. ISSUE . P. - 37 79% 28
9 ATIF, M , AZEEM, M , SARWAR, MR , (2016) POTENTIAL PROBLEMS AND RECOMMENDATIONS REGARDING SUBSTITUTION OF GENERIC ANTIEPILEPTIC DRUGS: A SYSTEMATIC REVIEW OF LITERATURE.SPRINGERPLUS. VOL. 5. ISSUE . P. - 40 65% 2
10 CRAWFORD, P , FEELY, M , GUBERMAN, A , KRAMER, G , (2006) ARE THERE POTENTIAL PROBLEMS WITH GENERIC SUBSTITUTION OF ANTIEPILEPTIC DRUGS? A REVIEW OF ISSUES.SEIZURE-EUROPEAN JOURNAL OF EPILEPSY. VOL. 15. ISSUE 3. P. 165-176 37 79% 83

Classes with closest relation at Level 1


Rank Class id link
1 6092 MEDICARE PART D//PRIOR AUTHORIZATION//PRESCRIPTION DRUGS
2 28333 FOOD AND DRUG LAW JOURNAL//INTELLECTUAL PROPERTY PROGRAM//ADDITIONAL PATENT
3 16866 COMPULSORY LICENSING//ACCESS TO MEDICINES//DOHA DECLARATION
4 15410 FUNDHOLDING//PRESCRIBING COSTS//PRESCRIBING INDICATORS
5 21788 CRHAM//SOCIOL SUBJECT GRP//CORPORATE BIAS
6 7853 HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE//HTA
7 29146 TRANSFER PRICING//GRAY MARKETS//TRANSFER PRICE
8 32356 DRUG SHORTAGES//JAMES PARKINSON//MEDICINE SHORTAGES
9 13520 BIOEQUIVALENCE//INDIVIDUAL BIOEQUIVALENCE//HIGHLY VARIABLE DRUGS
10 16867 CLINICAL TRIAL RISK//DRUG DISCOVERY TODAY//TUFTS STUDY DRUG DEV

Go to start page